Stephen Rudolph
Internal Medicine · South Euclid, OHNPI 1790728988
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $525 and has fallen 76.7% since, to $122 in 2025.
Across 75 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$153
- Lifenet Health$122
- Amgen$97
- AbbVie$86
- Biohaven Pharmaceutical Holding Company Ltd.$78
- Novo Nordisk$74
- plus $655 from 23 others
What the payments were for
- Food & beverage$1,265100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $153 |
| Lifenet Health | 1 | $122 |
| Amgen | 7 | $97 |
| AbbVie(2 entities) | 5 | $86 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $78 |
| Novo Nordisk | 5 | $74 |
| Pfizer | 4 | $62 |
| Novartis | 3 | $61 |
| E.r. Squibb & Sons, L.L.C. | 4 | $60 |
| Merck | 4 | $49 |
| Supernus Pharmaceuticals, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Gilead | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $28 |
| Johnson & Johnson | 2 | $28 |
| Hikma Pharmaceuticals USA | 2 | $25 |
| Bausch Health US, LLC | 1 | $23 |
| Abbott | 1 | $23 |
| Astellas Pharma US Inc | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Shire North American Group Inc | 1 | $17 |
| VBI Vaccine (delaware) Inc. | 1 | $17 |
| GSK | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Boehringer Ingelheim | 1 | $11 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,265 in reported general payments places this provider in the 75th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in South Euclid
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.